140 related articles for article (PubMed ID: 31018876)
1. Effect of Ultra-Small Chitosan Nanoparticles Doped with Brimonidine on the Ultra-Structure of the Trabecular Meshwork of Glaucoma Patients.
Barwal I; Kumar R; Dada T; Yadav SC
Microsc Microanal; 2019 Dec; 25(6):1352-1366. PubMed ID: 31018876
[TBL] [Abstract][Full Text] [Related]
2. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
[TBL] [Abstract][Full Text] [Related]
3. Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug.
Park CG; Kim YK; Kim MJ; Park M; Kim MH; Lee SH; Choi SY; Lee WS; Chung YJ; Jung YE; Park KH; Choy YB
J Control Release; 2015 Dec; 220(Pt A):180-188. PubMed ID: 26478018
[TBL] [Abstract][Full Text] [Related]
4. OTC brimonidine (Lumify) for ocular redness.
Med Lett Drugs Ther; 2018 Oct; 60(1558):176. PubMed ID: 30335046
[No Abstract] [Full Text] [Related]
5. Amino-Functionalized Mesoporous Silica Particles for Ocular Delivery of Brimonidine.
Kim SN; Ko SA; Park CG; Lee SH; Huh BK; Park YH; Kim YK; Ha A; Park KH; Choy YB
Mol Pharm; 2018 Aug; 15(8):3143-3152. PubMed ID: 30020792
[TBL] [Abstract][Full Text] [Related]
6. α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
Jung KI; Kim JH; Park CK
Eur J Pharmacol; 2015 Oct; 765():274-83. PubMed ID: 26300392
[TBL] [Abstract][Full Text] [Related]
7. Allergic contact dermatitis to topical brimonidine.
Rajagopalan A; Rajagopalan B
Australas J Dermatol; 2015 Aug; 56(3):235. PubMed ID: 26201375
[No Abstract] [Full Text] [Related]
8. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Tsujinaka A; Takai Y; Inoue Y; Tanito M
Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
[No Abstract] [Full Text] [Related]
9. Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study.
Gautam N; Kesavan K
Curr Eye Res; 2021 Dec; 46(12):1844-1852. PubMed ID: 34176380
[No Abstract] [Full Text] [Related]
10. Bilateral granulomatous uveitis in an elderly female.
Kattige J; Konana VK; Babu K
Indian J Ophthalmol; 2019 Sep; 67(9):1391. PubMed ID: 31436179
[No Abstract] [Full Text] [Related]
11. Novel topical ophthalmic formulations for management of glaucoma.
Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
Pharm Res; 2013 Nov; 30(11):2818-31. PubMed ID: 23771565
[TBL] [Abstract][Full Text] [Related]
12. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
Cheng YH; Ko YC; Chang YF; Huang SH; Liu CJ
Exp Eye Res; 2019 Feb; 179():179-187. PubMed ID: 30471279
[TBL] [Abstract][Full Text] [Related]
13. [Brimonidine (Mirvaso), dermal use].
Van Genechten D
J Pharm Belg; 2015 Jun; (2):45-6. PubMed ID: 26466509
[No Abstract] [Full Text] [Related]
14. The Relationship of Brimonidine Concentration in Vitreous Body to the Free Concentration in Retina/Choroid Following Topical Administration in Pigmented Rabbits.
Shinno K; Kurokawa K; Kozai S; Kawamura A; Inada K; Tokushige H
Curr Eye Res; 2017 May; 42(5):748-753. PubMed ID: 27854122
[TBL] [Abstract][Full Text] [Related]
15. Trabecular meshwork as a new target for the treatment of glaucoma.
Ferrer E
Drug News Perspect; 2006 Apr; 19(3):151-8. PubMed ID: 16804567
[TBL] [Abstract][Full Text] [Related]
16. Low-dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials.
Ackerman SL; Torkildsen GL; McLaurin E; Vittitow JL
Clin Exp Optom; 2019 Mar; 102(2):131-139. PubMed ID: 30525235
[TBL] [Abstract][Full Text] [Related]
17. Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles.
Schnichels S; Hurst J; de Vries JW; Ullah S; Frößl K; Gruszka A; Löscher M; Bartz-Schmidt KU; Spitzer MS; Herrmann A
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9445-9456. PubMed ID: 33528240
[TBL] [Abstract][Full Text] [Related]
18. Development and Evaluation of Novel Polymeric Nanoparticles of Brimonidine Tartrate.
Singh KH; Shinde UA
Curr Drug Deliv; 2010 Jul; 7(3):244-51. PubMed ID: 20497099
[TBL] [Abstract][Full Text] [Related]
19. Brimonidine Induced Anterior Uveitis.
Beltz J; Zamir E
Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
[TBL] [Abstract][Full Text] [Related]
20. Ab interno trabeculectomy: development of a novel device (Trabectome) and surgery for open-angle glaucoma.
Francis BA; See RF; Rao NA; Minckler DS; Baerveldt G
J Glaucoma; 2006 Feb; 15(1):68-73. PubMed ID: 16378021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
